Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-045 - HER-2 Mutation Is Not a Prognostic Factor Treated with First-Line Chemotherapy in NSCLC Patients
09:30 - 09:30 | Presenter: Tao Jiang | Author(s): C. Zhao, X. Li, C. Su, X. Chen, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P1.03-052 - Comparing EGFR-TKI with EGFR-TKI plus Chemotherapy as 1st Line Treatment in Advanced NSCLC Patients with Both Mutated EGFR and Bim Polymorphism
09:30 - 09:30 | Presenter: Yayi He | Author(s): C. Zhao, X. Li, Shengxiang Ren, Tao Jiang, J. Zhang, C. Su, X. Chen, Weijing Cai, G. Gao, W. Li, Fengying Wu, J. Li, J. Zhao, Fei Zhou, Q. Hu, Fred R. Hirsch, Caicun Zhou
- Abstract
Loading...
-
+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P1.07-027 - PD-L1 Expression Analysis in African American (AA) and Hispanic Lung Cancer Patients at a Minority-Based Academic Cancer Center
09:30 - 09:30 | Presenter: Elaine Shum | Author(s): C. Su, C. Zhu, R.A. Gucalp, M. Haigentz Jr., S.H. Packer, R. Perez-Soler, Balazs Halmos, Haiying Cheng
- Abstract
Loading...
-
+
P1.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
-
+
P1.15-009 - Safety and Efficacy of Nab-Paclitaxel Monotherapy as 2nd or Later Line Setting in Pts with Extensive SCLC, a Phase II Single Arm Study (NCT02262897)
09:30 - 09:30 | Presenter: Shengxiang Ren | Author(s): G. Gao, W. Li, X. Chen, Fengying Wu, C. Su, J. Zhao, Y. Sun, Weijing Cai, Caicun Zhou
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-008 - Combination of Bavacizumab with Conventional Chemotherapy Shows Better Prognosis in Patients with Lung Cancer with Liver Metastasis
09:00 - 09:00 | Presenter: Kim Ki-Up | Author(s): C. Sung Jun, K. So-Mye
- Abstract
Loading... -
+
P2.01-062 - Primary Lung Adenocarcinoma in the Young with Multiple Metastases: An Autopsy Report of 2 Cases
09:00 - 09:00 | Presenter: Randell Santos Arias | Author(s): F.S. Templo, Jr., L.C. Subia, O.P.R. Balisan
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
- Abstract
Loading... -
+
P3.01-085 - A Phase 2 Trial of Apatinib in Advanced Non-Squamous NSCLC: Updated Data and Clinical Benefit of Continuing Apatinib after Initial Progression
09:30 - 09:30 | Presenter: Fengying Wu | Author(s): S. Zhang, J. Yu, G. Gao, W. Li, Weijing Cai, C. Su, X. Chen, S. Ren, Caicun Zhou
- Abstract
Loading...